2022

1. MDS-454 SF3B1 and DNMT3A Mutations Might Play a Role in Poor Prognosis and AML Progression in Patients With Isolated del(5q) MDS

   Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S316